Dietary interventions to contrast the onset and progression of diabetic nephropathy: A critical survey of new data. (Q31157315)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128635 AND SRC:MED&resulttype=core&format=json

9 April 2020

title

Dietary interventions to contrast the onset and progression of diabetic nephropathy: A critical survey of new data (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128635 AND SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128635 AND SRC:MED&resulttype=core&format=json

9 April 2020

Carla Iacobini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128635 AND SRC:MED&resulttype=core&format=json

9 April 2020

Giuseppe Pugliese

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128635 AND SRC:MED&resulttype=core&format=json

9 April 2020

Carlo Pesce

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128635 AND SRC:MED&resulttype=core&format=json

9 April 2020

publication date

13 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128635 AND SRC:MED&resulttype=core&format=json

Critical Reviews in Food Science and Nutrition

9 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128635 AND SRC:MED&resulttype=core&format=json

9 April 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128635 AND SRC:MED&resulttype=core&format=json

9 April 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128635 AND SRC:MED&resulttype=core&format=json

9 April 2020

page(s)

1671-1680

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128635 AND SRC:MED&resulttype=core&format=json

Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy

9 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Advanced glycation endproducts--role in pathology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Carnosine and related dipeptides as quenchers of reactive carbonyl species: from structural studies to therapeutic perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Sources of protein and polyunsaturated fatty acids of the diet and microalbuminuria in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Potential efficacy of broccoli sprouts as a unique supplement for management of type 2 diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Adipokines as a link between obesity and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

A randomized trial of low-protein diet in type 1 and in type 2 diabetes mellitus patients with incipient and overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Nutrition therapy for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Advanced glycation end products: sparking the development of diabetic vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Diabetic nephropathy: diagnosis, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Effect of a chicken-based diet on renal function and lipid profile in patients with type 2 diabetes: a randomized crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin a nephropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Adiponectin, resistin and leptin response to dietary intervention in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Obesity, metabolic syndrome and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Is low-protein diet a possible risk factor of malnutrition in chronic kidney disease patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Low-protein diet for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Molecular aspects of lipoic acid in the prevention of diabetes complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Updating the natural history of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Nutritional and metabolic consequences of the early Maillard reaction of heat treated milk in the pig. Significance for man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

A CTG polymorphism in the CNDP1 gene determines the secretion of serum carnosinase in Cos-7 transfected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

The HOPE Study (Heart Outcomes Prevention Evaluation).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Uremic Toxicity of Advanced Glycation End Products in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Influence of smoking and obesity on the development of proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Advanced glycation end products in foods and a practical guide to their reduction in the diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

AGE restriction in diabetes mellitus: a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Obesity and kidney disease: potential mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): a randomized, parallel, controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

Metabolic Syndrome, Cardiovascular Disease, and Risk for Chronic Kidney Disease in an Italian Cohort: Analysis of the INCIPE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

The metabolic syndrome and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408398.2016.1278355

10.1080/10408398.2016.1278355

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28128635 AND SRC:MED&resulttype=core&format=json

9 April 2020

1 reference